Company Encyclopedia
View More
name
KemaTek
301611.SZ
Suzhou KemaTek, Inc. engages in the research and development, production, processing, and sale of various ceramic components. The company offers oxide, nitride, carbide, and machinable ceramics; surface treatment services to external parties; and metal structural parts to external parties. Its products are applied in advanced equipment manufacturing, mechanical equipment, medical and pharmaceutical, new energy, electronic communications, as well as auto, textile, and chemical industries.
3.936 T
301611.SZMarket value -Rank by Market Cap -/-

Financial Score

12/12/2025 Update
B
Industrial Machinery and Supplies and ComponentsIndustry
Industry Ranking13/399
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE20.54%A
    • Profit Margin31.85%A
    • Gross Margin55.16%B
  • Growth ScoreA
    • Revenue YoY39.17%A
    • Net Profit YoY31.58%B
    • Total Assets YoY13.97%B
    • Net Assets YoY17.27%A
  • Cash ScoreB
    • Cash Flow Margin313.98%C
    • OCF YoY39.17%A
  • Operating ScoreC
    • Turnover0.45C
  • Debt ScoreB
    • Gearing Ratio29.75%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Ionis Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025

    Ionis Pharmaceuticals, Inc. reported its earnings for Q3 and the first nine months of 2025. Q3 revenue increased to USD 157 million from USD 134 million year-over-year, with a net loss of USD 129 million, an improvement from USD 140 million. For the nine months, revenue rose to USD 740 million from USD 479 million, with a net loss of USD 152 million, down from USD 350 million. Basic and diluted loss per share from continuing operations improved to USD 0.8 and USD 0.95 respectively, compared to USD 0.95 and USD 2.38 a year ago.

    marketscreener·
    US
    IONS
    +2.12%
    marketscreener·
    US
    IONS
    +2.12%

    KemaTek released its performance for the first three quarters, with a net profit attributable to the parent company of 245 million yuan, an increase of 8.29%

    According to the Zhitong Finance APP, KemaTek released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 794 million yuan, a year-on-year increase of 28.86%. The net profit attributable to shareholders of the listed company was 245 million yuan, a year-on-year increase of 8.29%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 244 million yuan, a year-on-year increase of 10.66%. The basic earnings per share were 0.56 yuan

    Zhitong·
    SZ
    301611
    +6.85%
    Zhitong·
    SZ
    301611
    +6.85%

    Midday Announcement: KemaTek's application for issuing convertible bonds has been accepted

    KemaTek: The company has issued convertible corporate bonds to unspecified objects and has been accepted by the Shenzhen Stock Exchange

    Zhitong·
    SZ
    301611
    +6.85%
    Zhitong·
    SZ
    301611
    +6.85%

    Lithography machine concept stocks fluctuate and rise, KAIMEITE GASES hits the limit up

    Lithography machine concept stocks fluctuated upward, with KINGLAI MATERIALS hitting a new high during the session, KAIMEITE GASES reaching the daily limit, FORTUNE PRECISION rising over 10%, and Guangliwei, Huate Gas, and KemaTek following suit

    Zhitong·
    SH
    688268
    +3.62%
    SZ
    301611
    +6.85%
    SZ
    300260
    +2.66%
    Zhitong·
    SH
    688268
    +3.62%
    SZ
    301611
    +6.85%
    SZ
    300260
    +2.66%

    KemaTek plans to launch a restricted stock incentive plan in 2025

    KemaTek released a draft of the 2025 restricted stock incentive plan, planning to grant 1.3 million restricted shares, accounting for 0.3% of the company's total equity. Among them, 1.04 million shares are for the initial grant, and 260,000 shares are reserved, with a grant price of 27.62 yuan per share. The plan is valid for a maximum of 48 months

    Zhitong·
    SZ
    301611
    +6.85%
    Zhitong·
    SZ
    301611
    +6.85%
    © 2025 Longbridge｜Disclaimer